Antibody VH domains as small recognition units

Area of Science:

• Biotechnology
• Immunology
• Protein Engineering

Background:

• Developing minimal-sized immunoglobulin-based recognition units is crucial for advanced biotechnological applications.
• Existing antibody fragments often require paired domains, limiting their size and application scope.

Purpose of the Study:

• To design and select single human heavy chain variable domains (VH) for antigen recognition.
• To engineer VH domains that mimic camelid heavy chains, naturally lacking light chain partners.
• To optimize VH domains for stability, expression, and high-affinity antigen binding.

Main Methods:

• A human VH domain was engineered with mutations (G44E, L45R, W47G) to prevent light chain variable domain (VL) interaction.
• The third hypervariable loop was randomized to create a diverse phage display library (2 x 10^8 clones).
• Phage display selection was performed using hapten and protein antigens to isolate specific VH clones.

Main Results:

• Specific VH clones targeting hapten and protein antigens were successfully isolated.
• Soluble VH expression was improved using an isoleucine residue at position 47, enhancing stability.
• Isolated VH domains demonstrated high specificity, stability, and good expression in E. coli, with affinities for haptens between 100-400 nM.

Conclusions:

• Engineered single human VH domains can function as effective antigen-binding units.
• These minimal-sized VH domains possess favorable biophysical properties, making them suitable for diverse biotechnological applications.
• The design strategy successfully created stable, specific, and well-expressed antibody fragments.